Establishment Labs (ESTA) Projected to Post Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA - Get Free Report) is projected to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Establishment Labs to post earnings of ($0.64) per share and revenue of $44.45 million for the quarter. Individual interested in participating in the company's earnings conference call can do so using this link.

Establishment Labs Trading Down 4.6 %

NASDAQ ESTA traded down $1.62 during mid-day trading on Friday, hitting $33.41. The company's stock had a trading volume of 559,219 shares, compared to its average volume of 446,351. Establishment Labs has a 52-week low of $28.16 and a 52-week high of $60.12. The stock's fifty day simple moving average is $37.89 and its two-hundred day simple moving average is $41.39. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The firm has a market capitalization of $935.56 million, a P/E ratio of -12.95 and a beta of 1.12.

Analysts Set New Price Targets

Separately, Stephens upgraded shares of Establishment Labs to a "strong-buy" rating in a report on Monday, December 2nd. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.